LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE

Clinical trials for LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE trials appear

Sign up with your email to follow new studies for LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for kids with tough leukemia: testing gentler, targeted treatment

Disease control Not yet recruiting

This study is testing a new combination of drugs for children and young adults (ages 1-30) whose acute lymphoblastic leukemia (ALL) has come back or hasn't responded to other treatments. The goal is to see if adding a new targeted drug (asciminib) to a lower-dose chemotherapy and…

Matched conditions: LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE

Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 02, 2026 15:28 UTC

LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE

Get alerted when new LEUKEMIA, LYMPHOBLASTIC, ACUTE, PHILADELPHIA-POSITIVE trials appear

New hope for kids with tough leukemia: testing gentler, targeted treatment